Darzalex 100mg

$540

Active ingredient: daratumumab 100 mg
Manufactured by: Janssen
Country of origin: Germany
Package language: English
1 vial

Description

Darzalex 100mg (daratumumab 100 mg) is a prescription medicine used to treat multiple myeloma:

  • In combination with the medicines bortezomib, melphalan and prednisone, in people with newly diagnosed multiple myeloma who cannot receive a type of stem cell transplant that uses their own stem cells (autologous stem cell transplant).
  • In combination with the medicines lenalidomide and dexamethasone, or bortezomib and dexamethasone, in people who have received at least one prior medicine to treat multiple myeloma.
  • In combination with the medicines pomalidomide and dexamethasone in people who have received at least two prior medicines to treat multiple myeloma, including lenalidomide and a proteasome inhibitor.

Alone in people who have received at least three prior medicines to treat multiple myeloma, including a proteasome inhibitor and an immunomodulatory agent, or did not respond to a proteasome inhibitor and an immunomodulatory agent.

Darzalex 100 mg (daratumumab 100mg) is a treatment used to treat a type of cancer called multiple myeloma. Depending on where you are in your treatment journey, your doctor may discuss treatment with Darzalex 100mg (daratumumab 100 mg) as:

  • part of a combination therapy in combination with Revlimid (lenalidomide) and dexamethasone or Velcade (bortezomib) and dexamethasone if you have received at least 1 prior medicine
  • part of a combination therapy with the medicines Pomalyst / Imnovid (pomalidomide) and dexamethasone in people who have received at least two prior medicines to treat multiple myeloma, including lenalidomide and a proteasome inhibitor (PI)
  • a monotherapy if you have received at least 3 prior medicines, including an immunomodulatory agent, such as Revlimid, and a PI, such as Velcade, or if you did not respond to a PI and an immunomodulatory agent

The most common side effects of Darzalex 100 mg (daratumumab 100 mg) include:

  • tiredness
  • nausea
  • diarrhea
  • shortness of breath
  • trouble sleeping
  • fever
  • cough
  • muscle spasms
  • back pain
  • joint pain
  • vomiting
  • cold-like symptoms (upper respiratory infection)
  • nerve damage causing tingling, numbness or pain
  • swollen hands, ankles or feet
  • constipation
  • chills
  • dizziness

Contact us

You may also like…